- Home
- OABI vs USAS Comparison
OABI vs USAS Comparison
Compare OABI & USAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OABI
- USAS
- Stock Information
- Founded
- OABI 2012
- USAS 1998
- Country
- OABI United States
- USAS Canada
- Employees
- OABI N/A
- USAS N/A
- Industry
- OABI Biotechnology: Pharmaceutical Preparations
- USAS Metal Mining
- Sector
- OABI Health Care
- USAS Basic Materials
- Exchange
- OABI Nasdaq
- USAS Nasdaq
- Market Cap
- OABI 307.4M
- USAS 286.7M
- IPO Year
- OABI N/A
- USAS N/A
- Fundamental
- Price
- OABI $2.28
- USAS $0.50
- Analyst Decision
- OABI Strong Buy
- USAS Strong Buy
- Analyst Count
- OABI 3
- USAS 1
- Target Price
- OABI $7.00
- USAS $1.00
- AVG Volume (30 Days)
- OABI 780.2K
- USAS 968.6K
- Earning Date
- OABI 03-18-2025
- USAS 03-27-2025
- Dividend Yield
- OABI N/A
- USAS N/A
- EPS Growth
- OABI N/A
- USAS N/A
- EPS
- OABI N/A
- USAS N/A
- Revenue
- OABI $26,391,000.00
- USAS $100,188,000.00
- Revenue This Year
- OABI $77.72
- USAS $59.01
- Revenue Next Year
- OABI $30.95
- USAS $8.16
- P/E Ratio
- OABI N/A
- USAS N/A
- Revenue Growth
- OABI N/A
- USAS 18.02
- 52 Week Low
- OABI $2.23
- USAS $0.21
- 52 Week High
- OABI $5.54
- USAS $0.60
- Technical
- Relative Strength Index (RSI)
- OABI 27.98
- USAS 43.12
- Support Level
- OABI $2.38
- USAS $0.45
- Resistance Level
- OABI $2.57
- USAS $0.59
- Average True Range (ATR)
- OABI 0.18
- USAS 0.04
- MACD
- OABI -0.04
- USAS -0.00
- Stochastic Oscillator
- OABI 4.42
- USAS 8.50
About OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. The company focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.
About USAS Americas Gold and Silver Corporation no par value
Americas Gold And Silver Corp is a mining company engaged in the acquisition, exploration, development, and production of precious metals mineral properties in Mexico and the United States. The company's primary operating assets are The Cosala operations, The Galena Complex, and Relief Canyon. The company also holds interests in the San Felipe Development Project located in Sonora, Mexico. It has geographic focus is the Western Hemisphere, particularly the United States and Mexico.